- Home
- AMRN vs TELO Comparison
AMRN vs TELO Comparison
Compare AMRN & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- TELO
- Stock Information
- Founded
- AMRN 1989
- TELO 2021
- Country
- AMRN Ireland
- TELO United States
- Employees
- AMRN N/A
- TELO N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- TELO
- Sector
- AMRN Health Care
- TELO
- Exchange
- AMRN Nasdaq
- TELO NYSE
- Market Cap
- AMRN 189.2M
- TELO 154.1M
- IPO Year
- AMRN 1993
- TELO 2024
- Fundamental
- Price
- AMRN $0.56
- TELO $4.69
- Analyst Decision
- AMRN Buy
- TELO
- Analyst Count
- AMRN 1
- TELO 0
- Target Price
- AMRN N/A
- TELO N/A
- AVG Volume (30 Days)
- AMRN 1.7M
- TELO 225.7K
- Earning Date
- AMRN 02-27-2025
- TELO 02-12-2025
- Dividend Yield
- AMRN N/A
- TELO N/A
- EPS Growth
- AMRN N/A
- TELO N/A
- EPS
- AMRN N/A
- TELO N/A
- Revenue
- AMRN $241,021,000.00
- TELO N/A
- Revenue This Year
- AMRN N/A
- TELO N/A
- Revenue Next Year
- AMRN N/A
- TELO N/A
- P/E Ratio
- AMRN N/A
- TELO N/A
- Revenue Growth
- AMRN N/A
- TELO N/A
- 52 Week Low
- AMRN $0.43
- TELO $3.11
- 52 Week High
- AMRN $1.37
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- AMRN 60.59
- TELO 50.83
- Support Level
- AMRN $0.43
- TELO $4.05
- Resistance Level
- AMRN $0.49
- TELO $5.17
- Average True Range (ATR)
- AMRN 0.03
- TELO 0.45
- MACD
- AMRN 0.01
- TELO 0.03
- Stochastic Oscillator
- AMRN 91.43
- TELO 58.62
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.